Plasma adiponectin distribution in a Mediterranean population and its association with cardiovascular risk factors and metabolic syndrome

Metabolism: Clinical and Experimental

Volumn 56, Issue 11, 2007, Pages 1486-1492

  Salas Salvadó, Jordi ^a   Granada, Marisa ^b   Bulló, Mònica ^a   Corominas, Augusto ^b   Casas, Patricia ^a   Foz, Màrius ^c  

^a Institute of Legal Medicine Forensic Toxicology Service Faculty of Medicine   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c Centre Català de la Nutrició   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH SURVEY; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RADIOIMMUNOASSAY; SEX DIFFERENCE; SPAIN; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADIPOSITY; ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MEDITERRANEAN REGION; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS;

EID: 35248847979     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.06.014     Document Type: Article

References (34)

1. Bays H., Mandarino L., and DeFronzo R.A. Role of adipocyte, free fatty acids, and ectopic fat in the pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 89 (2004) 463-478
2. Maeda K., Okubo K., Shimomura I., Funahashi T., Matsuzawa Y., and Matsubara K. cDNA cloning and expression of a novel adipose-specific collagen-like factor, apM1 (Adipose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221 (1996) 286-289
3. Yamauchi T., Kamon J., Waki H., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with lipoatrophy and obesity. Nat Med 7 (2001) 941-946
4. Yamauchi T., Kamon J., Waki H., et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem 278 (2003) 2461-2468
5. Weyer C., Funahashi T., Tanaka S., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
6. Hotta K., Funahashi T., Arita Y., et al. Plasma concentration of a novel-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2000) 1595-1599
7. Yang W.S., Lee W.J., Funahashi T., et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86 (2001) 3815-3819
8. Baratta R., Amato S., degano C., et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab 89 (2004) 2665-2671
9. Ouchi N., Nihara S., Arita Y., et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100 (1999) 2473-2476
10. Ouchi N., Kihara S., Arita Y., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kB signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
11. Arita Y., Kihara S., Ouchi N., et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105 (2002) 2893-2898
12. Ouchi N., Kihara S., Arita S., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103 (2001) 1057-1063
13. Ouchi N., Ohishi M., Kihara S., et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 42 (2003) 231-234
14. Cnop M., Havel P.J., Utzschneider K.M., et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46 (2003) 459-469
15. Juncá S., Guillén M., Aragay J.M., et al. Methodological aspects in the evaluation of health and risk-reduction objectives of Health Plan for Catalonia for the year 2000. Med Clin (Barc) 121 Suppl 1 (2003) 10-19
16. SEEDO'2000 consensus for the evaluation of overweight and obesity and the establishment of criteria for therapeutic intervention. Sociedad Española para el Estudio de la Obesidad. Med Clin (Barc) 115 (2000) 587-597
17. Friedewald W.T., and Levy R.I. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
18. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28 (1985) 412-441
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
20. Adamczack M., Rzepkat E., Chudek J., and Wiecek A. Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol 62 (2005) 114-118
21. Vilarassa N., Vendrell J., Maravall J., et al. Distribution and determinants of adiponectin, resisitin and ghrelin in a randomly selected healthy population. Clin Endocrinol 63 (2005) 329-335
22. Yamamoto Y., Hirose H., Saito I., Tomita M., Taniyama M., Matsubara K., et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci 103 (2002) 137-142
23. Ryan A., Berman D., Nicklas B., et al. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 26 (2003) 2383-2388
24. DeFronzo R.A. Glucose intolerance of aging. Evidence for tissue insensitivity to insulin. Diabetes 28 (1979) 1095-1101
25. Chen M., Bergman R.N., Pacini G., and Porte D. Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased β-cell function. J Clin Endocrinol Metab 60 (1985) 13-20
26. Schwartz R.S., Shuman W.P., Bradbury V.L., et al. Body distribution in healthy young and older men. Journal of Gerontology 45 (1990) M181-M185
27. Colman E., Katzel L.I., Rogus E., Coon P., Muller D., and Goldberg A.P. Weight loss reduces abdominal fat and improves insulin action middle-aged and older men with impaired glucose tolerance. Metabolism 44 (1995) 1502-1508
28. Ryo M., Nakamura T., Kihara S., et al. Adiponectin as a biomarker of the metabolic syndrome. Circulation Journal 68 (2004) 975-981
29. Nishizawa H., Shimomura I., Kishida K., et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51 (2002) 2734-2741
30. Combs T.P., Berg A.H., Rajala M.W., et al. Sexual differentiation, pregnancy, caloric restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52 (2003) 268-276
31. Motoshima H., Wu X., Sinha M.K., et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. Diabetes 51 Suppl 2 (2002) A-88
32. Kwon K., Jung S.H., Choi C., and Park S.H. Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women. Int J Cardiol 101 (2005) 385-390
33. Maeda N., Takahashi M., Funahashi T., et al. PPAR-gamma ligands increase expression and plasma concentrations of adiponectin, and adipose-derived protein. Diabetes 50 (2001) 2094-2099
34. Lindsay R.S., Funahashi T., Hanson R.L., et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360 (2002) 57-58